Artemisome (UK) Fund
| 0P0000KKC4 | 284.71 3.92 1.36% |
Performance0 of 100
|
Artemisome is selling for 284.71 as of the 20th of December 2024. This is a 1.36 percent decrease since the beginning of the trading day. The fund's last reported lowest price was 284.71. Artemisome has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 23rd of June 2024 and ending today, the 20th of December 2024. Click here to learn more.
Artemisome I Risk Profiles
Although Artemisome's alpha and beta are two of the key measurements used to evaluate Artemisome's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.5327 | |||
| Standard Deviation | 0.6655 | |||
| Variance | 0.4429 | |||
| Risk Adjusted Performance | (0.02) |
Artemisome Against Markets
Artemisome Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Artemisome fund to make a market-neutral strategy. Peer analysis of Artemisome could also be used in its relative valuation, which is a method of valuing Artemisome by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |